Clinical Trials Directory

Trials / Completed

CompletedNCT05216068

Investigation and Diagnosis of the Chromosome Variation in Donated/abandoned Blastocyst

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
57 (actual)
Sponsor
Chang Gung Memorial Hospital · Academic / Other
Sex
Female
Age
20 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Blastocysts derived from patients seeking infertility treatment were generated by in vitro fertilization and embryo culture as previously described, and were evaluated using the Gardner system. As part of the embryo selection process, cells of TE biopsy were collected, and blastocysts were vitrified. The clinical TE biopsies were subjected to whole genome amplification (WGA) with SurePlex reagents (Illumina) followed by NGS-based PGT-A using Illumina's VeriSeq kit (Illumina) on a MiSeq system (Illumina) according to the manufacturer's protocol.

Detailed description

Collected 200 donate abandonment embryos (well-developed blastocysts) for research under the National Assisted Reproduction Act of Taiwan. 1. Collected 200 donate abandonment embryos: Five to six days after egg retrieval, well-developed embryos (called blastocysts). 2. Blastocysts derived from patients seeking infertility treatment were generated. 3. Embryos biopsies for PGT-A (by use of NGS platforms from our institute) will be used for the validation of our Lab QC embryo. 4. To standardize the operating procedures 5. Paper writing.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTNGSBased on the next generation sequencing (NGS), WES can identify single nucleotide variants (SNVs) and small variants.

Timeline

Start date
2021-12-01
Primary completion
2024-11-30
Completion
2024-11-30
First posted
2022-01-31
Last updated
2025-02-20

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05216068. Inclusion in this directory is not an endorsement.